We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VLTO icon
776
Veralto
VLTO
$23.2B
$1.5M 0.01%
+14,877
New +$1.44M
ALC icon
777
Alcon
ALC
$33B
$1.5M 0.01%
17,000
– –
PGAC
778
Pantages Capital Acquisition Corp
PGAC
$1.49M 0.01%
+146,800
New +$1.48M
WGO icon
779
Winnebago Industries
WGO
$882M
$1.49M 0.01%
51,500
– –
ARKO icon
780
ARKO Corp
ARKO
$906M
$1.48M 0.01%
350,500
+17,500
+5% +$76.4K
CNMD icon
781
CONMED
CNMD
$1.31B
$1.47M 0.01%
28,200
– –
SOLV icon
782
Solventum
SOLV
$14B
$1.47M 0.01%
19,329
+16,124
+503% +$1.14M
WTTR icon
783
Select Water Solutions
WTTR
$2.34B
$1.46M 0.01%
+169,506
New +$1.46M
UHS icon
784
Universal Health Services
UHS
$9.78B
$1.45M 0.01%
+8,016
New +$1.45M
M icon
785
Macy's
M
$6.56B
$1.45M 0.01%
124,500
+500
+0.4% +$5.79K
HSII
786
DELISTED
Heidrick & Struggles
HSII
$1.42M 0.01%
+31,006
New +$1.3M
RUSHA icon
787
Rush Enterprises Class A
RUSHA
$6.01B
$1.41M 0.01%
+27,438
New +$1.39M
VRT icon
788
Vertiv
VRT
$108B
$1.41M 0.01%
11,000
– –
BBWI icon
789
Bath & Body Works
BBWI
$4.11B
$1.41M 0.01%
+46,994
New +$1.38M
LFUS icon
790
Littelfuse
LFUS
$10B
$1.41M 0.01%
6,200
-824
-12% -$163K
SRAD icon
791
Sportradar
SRAD
$4.35B
$1.4M 0.01%
50,000
+33,000
+194% +$784K
INSE icon
792
Inspired Entertainment
INSE
$188M
$1.38M 0.01%
169,000
+16,000
+10% +$124K
HSBC icon
793
HSBC
HSBC
$354B
$1.38M 0.01%
22,700
– –
ALLY icon
794
Ally Financial
ALLY
$13.2B
$1.37M 0.01%
35,210
+5,525
+19% +$191K
SAP icon
795
SAP
SAP
$202B
$1.37M 0.01%
4,500
– –
AOS icon
796
A.O. Smith
AOS
$8.59B
$1.36M 0.01%
20,800
– –
IRDM icon
797
Iridium Communications
IRDM
$4.84B
$1.36M 0.01%
45,000
+22,000
+96% +$572K
LILAK icon
798
Liberty Latin America Class C
LILAK
$1.54B
$1.35M 0.01%
238,981
-9,627
-4% -$47.2K
ZIMV
799
DELISTED
ZimVie
ZIMV
$1.34M 0.01%
143,630
+40,230
+39% +$367K
BOOM icon
800
DMC Global
BOOM
$117M
$1.34M 0.01%
166,257
+8,442
+5% +$59.7K
30 31
32
33 34

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.